| Promising results from a multi-center
trial for a medication for children with autism has been published
in the New England Journal of Medicine. The IU School of Medicine's
Department of Psychiatry was one of the five sites testing the drug,
which is one of a newer class of anti-psychotic medications. Co-author
of the article is Dr. Christopher McDougle, the Albert Eugene Sterne
Professor of clinical psychiatry and chair of psychiatry at the IUSM.
The medication, risperidone, was successful and well tolerated for the treatment of serious behavioral disturbance associated with autistic disorder in children ages 5 to 17. The clinical trial is funded by the National Institute of Mental Health. http://www.medicine.indiana.edu/news_releases/archive_02/autism.html
|